We are live on ! Find out more
INTS icon

Intensity Therapeutics
INTS

21 hedge funds and large institutions have $5.1M invested in Intensity Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

6% more capital invested

Capital invested by funds: $4.79M → $5.1M (+$309K)

5% more funds holding

Funds holding: 20 → 21 (+1)

0.04% less ownership

Funds ownership: 0.72% → 0.68% (-0.04%)

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SC
Sapient Capital
Indiana
+$75.5K
2
SL
Sentinus LLC
Illinois
+$60.7K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$48.4K
4
MFIM
Mesirow Financial Investment Management
Illinois
+$44.5K
5
Northern Trust
Northern Trust
Illinois
+$31.2K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$566K
2
GS
GTS Securities
New York
-$33.7K
3
BlackRock
BlackRock
New York
-$945
4
TRCT
Tower Research Capital (TRC)
New York
-$612
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
1
Sapient Capital
Indiana
$1.92M +$75.5K +1,358 +4%
AC
2
Armistice Capital
New York
$1.72M -$566K -10,173 -23%
Vanguard Group
3
Vanguard Group
Pennsylvania
$454K +$48.4K +871 +10%
Brown Advisory
4
Brown Advisory
Maryland
$256K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$153K +$29.2K +525 +20%
SPC
6
Sigma Planning Corp
Michigan
$108K – – –
MFIM
7
Mesirow Financial Investment Management
Illinois
$78.8K +$44.5K +800 +100%
William Blair & Company
8
William Blair & Company
Illinois
$74.5K – – –
OCPWS
9
One Charles Private Wealth Services
Massachusetts
$62.6K – – –
SL
10
Sentinus LLC
Illinois
$53.8K +$60.7K +1,092 New
Citadel Advisors
11
Citadel Advisors
Florida
$50.8K +$24.1K +433 +72%
BlackRock
12
BlackRock
New York
$43K -$945 -17 -2%
QFW
13
QTR Family Wealth
Florida
$34.3K +$38.8K +697 New
State Street
14
State Street
Massachusetts
$28.6K – – –
Northern Trust
15
Northern Trust
Illinois
$27.6K +$31.2K +561 New
SFGP
16
Stonebridge Financial Group (Pennsylvania)
Pennsylvania
$18.8K +$2.73K +49 +15%
UBS Group
17
UBS Group
Switzerland
$6.1K +$167 +3 +2%
TRCT
18
Tower Research Capital (TRC)
New York
$4.68K -$612 -11 -10%
Morgan Stanley
19
Morgan Stanley
New York
$985 – – –
Bank of America
20
Bank of America
North Carolina
$124 +$56 +1 +50%
JP Morgan Chase
21
JP Morgan Chase
New York
$30 – – –
GS
22
GTS Securities
New York
– -$33.7K -761 Closed

INTS Hedge Fund Activity: Q1 2025 in Review

21 of the 7,463 institutional investors tracked by Wall St. Rank reported a position in Intensity Therapeutics (INTS) for Q1 2025, worth a combined $5.1M — up 6.4% from $4.79M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new INTS positions and 1 closed out — a net gain of 2 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was Sapient Capital, adding an estimated $75.5K. The largest seller was Armistice Capital, cutting an estimated $566K.

  • 21 institutional investors held Intensity Therapeutics (INTS) as of Q1 2025, up from 20 in Q4 2024.
  • Funds reported $5.1M of Intensity Therapeutics stock for Q1 2025, up 6.4% quarter-over-quarter.
  • 3 funds opened new Intensity Therapeutics positions in Q1 2025 and 1 closed out, a net change of +2 holders.
  • The largest Intensity Therapeutics buyer in Q1 2025 was Sapient Capital, an estimated $75.5K added.
  • The largest Intensity Therapeutics seller in Q1 2025 was Armistice Capital, an estimated $566K sold.

Based on aggregated 13F filings for Q1 2025.